When a Healthcare Giant Gets Sick: Elevance Health's 20% YTD DeclineZacks Investment Research • 08/11/25
Elevance Health Board Welcomes Steve Collis as New Director, Reflecting Ongoing Commitment to Governance ExcellenceBusiness Wire • 07/28/25
Study Finds Digital Asthma Program Significantly Improves Symptom Control in AdultsBusiness Wire • 07/22/25
S&P 500 Gains and Losses Today: Pepsi Stock Turns Higher; Elevance Health TumblesInvestopedia • 07/17/25
Elevance Health Q2 Earnings Miss Estimates on Rising Medical CostsZacks Investment Research • 07/17/25
Elevance Health (ELV) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 07/17/25
Elevance Stock Falls After Earnings. What It Means for UnitedHealth, Other Insurers.Barrons • 07/17/25
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net IncomeSeeking Alpha • 07/17/25
Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?Zacks Investment Research • 07/14/25
Elevance Health (ELV) Q2 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research • 07/14/25
ELV Deadline: ELV Investors with Losses in Excess of $100K Have Opportunity to Lead Elevance Health, Inc. Securities Fraud LawsuitPRNewsWire • 07/11/25
FINAL ELV DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Elevance Health, Inc. and Urgently Encourages Investors to Contact the FirmGlobeNewsWire • 07/11/25